Assessment of tumor stroma response to nab-placlitaxel (Abraxane) in combination with gemcitabine in pancreatic cancer.[Determinacion de la respuesta del estroma a nab-paclitaxel en combinacian con gemcitabina en cancer de pancreas.]
Phase of Trial: Phase II
Latest Information Update: 12 Mar 2013
At a glance
- Drugs Paclitaxel (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 01 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Sep 2011 Planned end date changed from 1 Jan 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.